Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Analysis of 23 promising “CUBs” i.e. small-cap companies with robust long-term growth potential by Nuvama



Under the CUB series banner, Nuvama covers small-cap companies with robust long-term growth potential.

Its endeavour is to recommend smallcap companies that are not widely covered. Despite low liquidity and small size of business, these companies have strong long-term fundamentals and sustainable structural growth drivers.

Nuvama is of the view that investment themes in equity markets play out over the long-term with potential pay-offs taking time to materialize.

By introducing the CUB series its objective is to identify quality small-cap companies in the early stages of their growth cycle.

The CUB series

1. Beta Drugs Ltd
2. Brand Concepts Ltd
3. CPS Shapers Ltd
4. Creative Graphics Solution Ltd
5. Dhampur Bio Organics Ltd
6. Essen Speciality Films Ltd
7. GPT Infraprojects Ltd
8. Kamat Hotels Ltd
9. Kilburn Engineering Ltd
10. Knowledge Marine & Engineering Works Ltd
11. Krishna Defence & Allied Services Ltd
12. MCON Rasayan India Ltd
13. Newjaisa Technologies Ltd
14. Oriana Power Ltd
15. Pyramid Technoplast Ltd
16. Rocking Deals Circular Economy Ltd
17. Saakshi Medtech & Panels Ltd
18. Seamec Ltd
19. Sky Gold Ltd
20. Softtech Engineers Ltd
21. Synergy Green Industries Ltd
22. Vasa Denticity Ltd
23. Vascon Engineers Ltd

Click here to download Analysis report of 23 CUBs i.e. small-cap companies

investments

No Comments Yet

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 494 other subscribers

RSS Stocks Talk Forum

  • Shalby is a multi-specialty hospital chain with expertise in joint replacement
    Shalby is a multi-specialty hospital chain with expertise in joint replacement. It is making right strides with calibrated growth based on big ticket expansion in metros & tier I cities & asset-light franchisee expansion in tier II-VI towns. TP ₹310 (35%) Download... Shalby is a multi-specialty hospital chain with expertise in joint replacement
  • DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
    DLF has strong growth prospects due to strong sectoral tailwinds, record low inventory, greater preference for branded luxury, extensive launch pipeline & expansion in its annuity portfolio. Strong Balance Sheet with consistent cash flow. TP ₹1081 (+30%) Research Report... DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
  • Aditya Birla Capital has demonstrated solid performance. Buy for target price of ₹280 (37% upside)
    Aditya Birla Capital has demonstrated solid performance, achieving strong growth in the loan book while maintaining asset quality. Management has reiterated guidance on both growth & credit cost fronts. Lending business expected to grow at 30%. TP (+37%)... Aditya Birla Capital has demonstrated solid performance. Buy for target price of ₹280 (37% upside)
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!